Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended	9 Months Ended
Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenue
Sales	$ 15,937		$ 48,021	$ 41,838
Grant revenue	34,964	85,577	127,009	170,092
Total revenue	50,901	85,577	175,030	211,930
Cost of sales	4,049		44,792	97,000
Gross profit	46,852	85,577	130,238	114,930
Operating expenses
Research and development	90,658	30,368	133,074	279,308
General and administrative	360,944	171,484	1,173,565	706,337
Total operating expenses	451,602	201,852	1,306,639	985,645
Operating loss	(404,750)	(116,275)	(1,176,401)	(870,715)
Other (income) and expenses
Other income	(93)		(190,193)	(191,566)
Change in fair value of convertible notes	193,776		195,962
Loss on extinguishment of convertible notes			934,257
Interest expense, net	41,066	72,768	189,993	211,927
Net loss	$ (639,499)	$ (189,043)	$ (2,306,420)	$ (891,076)
Net loss per share – basic and diluted (in Dollars per share)	$ (0.09)	$ (0.04)	$ (0.41)	$ (0.18)
Weighted average common shares – basic and diluted (in Shares)	7,171,232	4,864,862	5,642,100	4,864,862

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a),(d))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227